etabolic syndrome (MS) is characterized by a cluster of risk factors that increase the chance of cardiovascular disease (CVD). They include: glucose intolerance; hypertension; abdominal obesity; and dyslipidemia. 1 The World Health Organization (WHO) and the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III have separately proposed criteria for the clinical diagnosis of MS. 1,2 The WHO defines MS as a condition of insulin resistance and diabetes mellitus (DM) or impaired glucose tolerance with the presence of 2 or more of these components: obesity (body mass index (BMI) ≥30 kg/m 2 and/or waist-to-hip ratio (WHR) >0.9 and >0.85 for men and women, respectively); hypertension (blood pressure ≥140/90 mmHg); dyslipidemia (triglycerides (TG) ≥1. and microalbuminuria (urinary albumin-to-creatinine ratio (ACR) ≥30 g/mg). 1 The NCEP-ATP III criteria differ slightly with those of the WHO. 2 Subjects with type 2 DM (T2DM) show the highest risk of MS and CVD. Therefore understanding any correlation between CVD risk and the number of risk factors in a doseresponsive pattern, or the binary classification of MS or the components of MS, could well differentiate those patients at risk of ischemic heart disease (IHD) from those not at risk. As a result, the purpose of the present study examines the relation between IHD and (1) each component of MS, (2) the number of components of MS and (3) MS itself, in T2DM cases.
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Methods

Study Subjects
The present study was approved by an ethics committee with subjects participating voluntarily. Taiwan has an established cohort of 93,484 confirmed diabetic patients derived from a national sample of 256,036 patients under National Health Insurance cover, which covers over 96% of the total population. 3, 4 A health examination was planned for recruiting 1,400 patients from the main cluster. At random, 4,164 patients were selected from the main cluster and invited to participate in the health examination. A total of 1,441 patients accepted the invitation to this health examination and 1,420 patients were discovered to have T2DM. Among these T2DM patients, 1,296 patients (604 men and 692 women) had complete medical data for analyses in this present study. The mean age was 62.5±11.7 (14-87) years. All subjects were selected at random, thus a selection bias was not deemed to be an issue. In addition, no significant differences in age or sex were noted among the main national sample, those who participated in the health examination or those selected patients with T2DM.
Risk Factors and Definition of MS
The WHO criteria for MS were used with modifications. Patients with ≥2 of the following risk factors: obesity, hypertension, dyslipidemia or microalbuminuria, were defined as having MS.
Measurement of anthropometric factors and blood pressure were described elsewhere. 5, 6 Obesity was defined as a BMI ≥25 kg/m 2 and/or a waist circumference (WC) ≥90 cm for men or ≥80 cm for women. [7] [8] [9] These indicators are better predictors for MS, IHD and T2DM than the WHR indicator for CVD in T2DM patients in Taiwan. 5, 10 Patients were defined as having hypertension if undergoing antihypertensive treatments; having systolic blood pressure (SBP) ≥140 mmHg; or showing diastolic blood pressure (DBP) ≥90 mmHg. Patients who smoked one or more cigarettes per day were defined as smokers.
Subjects were instructed to avoid any vigorous physical activities one day before the examination to prevent any undue influence on the excretion of urinary albumin. Urine and blood samples were collected in the early morning after subjects fasted for a minimum of 12 h. First voided mid-stream urine was collected, then venous blood samples were collected. Urinary albumin concentrations were measured using a particle-enhanced turbidimetric immunoassay (Biolatex, Logroño, Spain). 11, 12 While, urinary creatinine concentrations were measured after dilution (×10) on an automated chemistry analyzer (Cobas Mira S, Roche Diagnostica, Basel, Switzerland) with reagents obtained from Randox Laboratories Ltd (Antrim, UK). ACRs ≥30 g/mg were defined as microalbuminuria. Fasting plasma glucose (FPG), hemoglobin A1c (HbA1c), serum total cholesterol (TC), TG, HDL-C and low-density lipoprotein-cholesterol (LDL-C) were measured as described. [11] [12] [13] Dyslipidemia was defined as a TG level ≥1.7 mmol/L and/or HDL-C <0.9 mmol/L for men or <1.0 mmol/L for women, or those undergoing treatment for lipid disorder.
Diagnosis of IHD
Diagnosis of IHD was based on one of the following criteria: (1) definite history of acute myocardial infarction (self-reported with previous diagnosis made by a physician); (2) definite history of angina pectoris with documented electrocardiographic findings and under specific therapy [self-reported history of chest pain with confirmed diagnosis by an electrocardiogram done previously by a physician and being treated with medications including sublingual nitroglycerine, coronary vasodilators or antiplatelet agents (eg, aspirin, ticlopidine, dipyridamole or clopidogrel etc)]; (3) patients who had received a placement of coronary stents, percutaneous transluminal coronary angioplasty, coronary artery bypass graft or had tested positive after a coronary angiography examination, a treadmill exercise test or a radionuclide test; and (4) for those without any of the above medical history, a resting electrocardiogram was performed and coded according to the Minnesota codes. 14 15 
Statistical Analyses
Performing the Student's t-test, the age between patients with and without IHD was compared and the chi-square test was used for the proportions of sex, smoking, hypertension, dyslipidemia and microalbuminuria. Because patients with IHD were significantly older than those without IHD, the differences of BMI, WC, SBP, DBP, FPG, HbA1c, TC, TG, HDL-C and LDL-C for those with and without IHD were compared by analysis of covariants (ANCOVA) adjusted for age. Prevalences of hypertension, dyslipidemia, obesity, microalbuminuria and MS in each age group and for both sexes were tested by linear test for trend and by chi-square test, respectively. Prevalences of IHD by the number of risk factors were tested by linear test for trend for the different age subgroups (<45, 45-54, 55-64 and ≥65 years) and for both sexes separately. Prevalences of IHD by age groups and by the different sexes were tested using a linear test for trend and chi-square test, respectively, in patients with a specific number of risk factors.
Prevalences of IHD with regards to the number of risk factors were tested by linear test for trend; and in those patients with and without MS, hypertension, dyslipidemia, obesity and microalbuminuria by chi-square test. Logistic regression models were created to estimate the unadjusted and the age-adjusted odds ratios (ORs) and their 95% confidence intervals (CIs) for IHD for the presence vs the absence of MS, hypertension, dyslipidemia, obesity and microalbuminuria; and for the subgroups of patients having 1, 2, 3 and 4 risk factors vs those without any risk factors.
In order to evaluate the relative impact of each risk factor of the MS on IHD, a logistic regression model including all 4 risk components of the MS, ie, hypertension, dyslipidemia, obesity and microalbuminuria, and other potential confounders such as age, sex, smoking, FPG and HbA1c was created.
Data were expressed as a mean and standard deviation or percentage. P<0.05 was considered statistically significant, and 0.05≤p<0.1 borderline significant. Table 1 compares the baseline characteristics between patients with and without IHD. Since patients with IHD were older than those without, the p values comparing the other continuous variables were analyzed using ANCOVA adjusted for age. IHD patients showed no gender differences. Subjects with IHD were more obese in terms of BMI or WC. The percentage of patients with hypertension and dyslipidemia was higher in patients with IHD. SBP was higher in patients with IHD, but DBP was comparable. For lipid profile, only TG was significantly higher in patients with IHD, and the other lipid parameters did not differ significantly. The percentage of microalbuminuria was higher in patients with IHD with borderline significance. Smoking and glycemic control, as indicated by FPG or HbA1c, were not significantly different.
Results
Age-and sex-specific prevalences of MS and each component of the risk factors are shown in Table 2 . Increasing prevalences of hypertension and MS with that of increasing age were observed in both sexes, respectively. In addition, the prevalences of obesity and microalbuminuria also in- Table 1 .
creased with that of increasing age in diabetic women. The prevalence of dyslipidemia showed no significant increasing trend with age in either sex. Differences in prevalences of MS and for the individual risk factors in each age stratum were not significantly different for both sexes, except for obesity in the age groups of 45-54, 55-64 and ≥65 years, and for microalbuminuria and MS in the age group ≥65 years. Table 3 shows the age-and sex-specific prevalences of IHD by number of risk factors. Except for the age group <45 years, IHD increased significantly with increasing number of risk factors in all other age groups and in both sexes. Table 4 shows the prevalences of IHD in different subgroups of risk classification and the respective ORs for IHD before and after adjustment for age. As shown in the table, 987 patients (76.2%) had MS. Of the 4 risk factors, hypertension was the most significant, with a 7-fold higher risk of IHD than those not suffering from hypertension. Microalbuminuria was the least significant, with ORs of borderline significance. However, the risk of IHD increased in conjunction with increasing number of risk factors. Table 5 shows the mutually adjusted ORs for IHD for all of the potential risk factors. Age, hypertension, dyslipidemia and obesity were significantly associated with IHD while the others were not.
Discussion
The high prevalence of MS (76.2%) is comparable to those reported in diabetic patients of other ethnicities. 16 Patients with MS had a 3-to 4-fold higher risk of IHD (Table 4) . However, hypertension seemed to be the most significant risk factor and microalbuminuria the least (Tables 4 and 5 ). This result of microalbuminuria being the least significant risk factor seems at odds with a study carried out in Finland and Sweden, where microalbuminuria conferred the strongest risk of cardiovascular death. 16 The reason for this discrepancy is not known. However, different ethnicities might experience different risk factors.
In one Japanese study, hypertension was a significant risk factor for the recurrence of coronary heart disease independent of age, sex, HbA1c, TC, BMI, smoking, family history and stenosis score, especially in patients with abnormal glucose tolerance and/or diabetes. 17 In order to see whether hypertension conferred a greater risk to IHD in patients with MS, we calculated the OR for patients with MS and hypertension vs those with MS but without hypertension after adjusting for age, sex, smoking, FPG and HbA1c in a second- ary analysis. The adjusted OR (95% CI) was 5.98 (4.30-8.32 ) with a p<0.001. In patients with only one risk factor of hypertension, dyslipidemia, obesity or microalbuminuria, respectively, only hypertension conferred significant risk for IHD while compared to those without any of the risk factors (data not shown). The different impact of risk factors on IHD (Tables 4 and 5 ) was very important in clinical practice because the risk of IHD could vary with different combinations of risk factors, and in patients with MS containing different components of risk factors. Because microalbuminuria was not significantly associated with IHD after adjustment for confounders (Table 5) , we reclassified the number of risk factors varying from 0 to 3 with regards to hypertension, dyslipidemia and obesity; and recalculated the age-adjusted ORs for IHD for the number of risk factors of 0, 1, 2 and 3. The respective adjusted ORs (95% CI) were 1.00, 1.48 (0.75-2.90), 3.67 (1.94-6.96) and 11.21 (5.85-21.48). However, in multivariate logistic regression models including both the number of risk factors and the various risk factors along with the adjustment for age, sex, smoking, FPG and HbA1c, it was found that the number of risk factors and microalbuminuria were not associated with IHD with statistical significance and the respective adjusted ORs (95% CI) for hypertension, dyslipidemia and obesity were 7.23 (5.15-10.16), 1.43 (1.01-2.00) and 1.61 (1.14-2.29). A similar finding of a lack of association with the number of risk factors was noted when microalbuminuria was not considered as a risk factor in the calculation of the number of risk factors (data not shown). Therefore it was the sort of risk factor but not the number of risk factors that was important.
TG is the only significant lipid parameter associated with IHD (Table 1) . This is compatible with most studies in Taiwan, showing TG as an independent and strong risk factor for atherosclerotic diseases. 18 However, it seems inappropriate to conclude that cholesterol is not important because in secondary analysis the prevalence of the use of statin in patients with IHD was significantly higher than in those without IHD (8.7% vs 3.8%, p<0.001).
Glycemic control seemed unimportant (Tables 1 and 5 ). This was further confirmed in secondary analyses estimating the ORs for FPG and HbA1c in separate models, without adjustment for confounders and after adjustment for age, sex, smoking, hypertension, dyslipidemia, obesity and microalbuminuria. None of these ORs was statistically significant (data not shown).
Smoking is a risk factor for IHD in the diabetic patients in some studies. 19, 20 The lack of an association in the present study (Tables 1 and 5 ) was consistent with our previous follow-up study for IHD incidence in patients with T2DM. 14 The effect of smoking might be more important in younger individuals than in the elderly. [21] [22] [23] Therefore the role of smoking on IHD in the diabetic patients with an average age of approximately 60 years in Taiwan requires further confirmation. 3 There are some limitations. First, the participants all had T2DM, therefore the results might not be applicable to those without diabetes or to patients with type 1 DM. Second, selection bias could not be completely excluded because we did not have any evidence of a similar distribution of IHD between the participants of the present study and the main national cohort. Third, the temporal correctness of cause and effect could not be evaluated in this crosssectional study.
Conclusions
The prevalence of MS in Taiwanese T2DM patients is 76.2% and increases with increasing age but does not differ much between men and women. Patients with MS have 3-to 4-fold higher risk of IHD. Among the 4 risk factors, hypertension, dyslipidemia, obesity and microalbuminuria, hypertension is the most significant and microalbuminuria the least. The impact of different risk factors on IHD is diverse. Therefore, it is important to estimate the risk of IHD based on individual risk factors.
